211 related articles for article (PubMed ID: 10193775)
21. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
Welch SP; Huffman JW; Lowe J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392
[TBL] [Abstract][Full Text] [Related]
22. Endothelium-derived hyperpolarizing factor, but not nitric oxide, is reversibly inhibited by brefeldin A.
Bauersachs J; Fleming I; Scholz D; Popp R; Busse R
Hypertension; 1997 Dec; 30(6):1598-605. PubMed ID: 9403589
[TBL] [Abstract][Full Text] [Related]
23. Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells.
Mombouli JV; Schaeffer G; Holzmann S; Kostner GM; Graier WF
Br J Pharmacol; 1999 Apr; 126(7):1593-600. PubMed ID: 10323591
[TBL] [Abstract][Full Text] [Related]
24. The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication.
Chaytor AT; Martin PE; Evans WH; Randall MD; Griffith TM
J Physiol; 1999 Oct; 520 Pt 2(Pt 2):539-50. PubMed ID: 10523421
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
Lay L; Angus JA; Wright CE
Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
[TBL] [Abstract][Full Text] [Related]
26. Anandamide induces cough in conscious guinea-pigs through VR1 receptors.
Jia Y; McLeod RL; Wang X; Parra LE; Egan RW; Hey JA
Br J Pharmacol; 2002 Nov; 137(6):831-6. PubMed ID: 12411414
[TBL] [Abstract][Full Text] [Related]
27. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed.
McCulloch AI; Randall MD
Br J Pharmacol; 1998 Apr; 123(8):1700-6. PubMed ID: 9605578
[TBL] [Abstract][Full Text] [Related]
28. The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1998 Oct; 125(3):533-41. PubMed ID: 9806337
[TBL] [Abstract][Full Text] [Related]
29. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
Ishioka N; Bukoski RD
J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011
[TBL] [Abstract][Full Text] [Related]
30. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries.
Vanheel B; Van de Voorde J
J Pharmacol Exp Ther; 2001 Feb; 296(2):322-8. PubMed ID: 11160613
[TBL] [Abstract][Full Text] [Related]
31. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF.
Zygmunt PM; Plane F; Paulsson M; Garland CJ; Högestätt ED
Br J Pharmacol; 1998 Jul; 124(5):992-1000. PubMed ID: 9692786
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels.
Romano MR; Lograno MD
Br J Pharmacol; 2006 Apr; 147(8):917-25. PubMed ID: 16474412
[TBL] [Abstract][Full Text] [Related]
33. Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).
Järbe TU; Lamb RJ; Liu Q; Makriyannis A
Psychopharmacology (Berl); 2006 Oct; 188(3):315-23. PubMed ID: 16953384
[TBL] [Abstract][Full Text] [Related]
34. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
[TBL] [Abstract][Full Text] [Related]
35. 2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor.
Kagota S; Yamaguchi Y; Nakamura K; Sugiura T; Waku K; Kunitomo M
Eur J Pharmacol; 2001 Mar; 415(2-3):233-8. PubMed ID: 11275004
[TBL] [Abstract][Full Text] [Related]
36. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
Adams IB; Compton DR; Martin BR
J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
[TBL] [Abstract][Full Text] [Related]
37. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the pharmacological properties of EDHF-mediated vasorelaxation in guinea-pig cerebral and mesenteric resistance vessels.
Dong H; Jiang Y; Cole WC; Triggle CR
Br J Pharmacol; 2000 Aug; 130(8):1983-91. PubMed ID: 10952691
[TBL] [Abstract][Full Text] [Related]
39. [Endothelium-derived hyperpolarizing factor].
Brăiloiu C; Beşchea-Chiriac C; Chiriac M
Rev Med Chir Soc Med Nat Iasi; 1998; 102(3-4):49-55. PubMed ID: 10756843
[TBL] [Abstract][Full Text] [Related]
40. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide.
Mallet PE; Beninger RJ
Psychopharmacology (Berl); 1998 Nov; 140(1):11-9. PubMed ID: 9862397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
